Use of cystatin C and SGLT2 inhibitors were highlighted in the Kidney Disease: Improving Global Outcomes (KDIGO) organization ...

A new guideline from the Kidney Disease: Improving Global Outcomes (KDIGO) group provides updated recommendations on the management of anemia in chronic kidney disease (CKD), reflecting substantial ...

An update to the Kidney Disease: Improving Global Outcomes (KDIGO) guidelines recommends finerenone (Kerendia), a first-in-class, nonsteroidal mineralocorticoid receptor antagonist (ns-MRA), as part ...

Credit: Getty Images The KDIGO 2024 chronic kidney disease guideline replaces the 2012 version and provides essential guidance on evaluating and managing the disease in all its facets. The new KDIGO ...

Please provide your email address to receive an email when new articles are posted on . As the structure grows internally for Kidney Disease: Improving Global Outcomes, the nonprofit organization has ...

Chronic Kidney Disease (CKD) is a widespread and underrecognized health crisis that silently affects millions of people, often progressing without noticeable symptoms until it’s advanced. Around 90 ...

An update from KDIGO, an independent organization that aims to improve the care of patients with kidney disease worldwide. A layered approach is recommended while caring for patients with diabetes and ...

The Kidney Disease: Improving Global Outcomes (KDIGO) group has updated chronic kidney disease treatment guidelines to help slow disease progression in adults. A JAMA article published Wednesday ...